CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 clinical trial of RTA 402 (bardoxolone methyl) in patients with chronic kidney disease and type 2 diabetes was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Chronic Kidney Disease, Type 2 Diabetes | Phase 2 | Status: TERMINATED